Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Czechia

Coordination and Support Action · Running

EIRENE IMP European InfrastRucturE for humaN Exposome research IMplementation Project

Coordinator
Masarykova univerzita, Czechia
Runs
1 June 2026 to 31 May 2029
Status
Running
EU funding
€1.4m
Total cost
—
Partners
25 organisations in 23 countries
Type
Coordination and Support Action
Grant agreement
101292721

What the project is doing

In the project's own words, from its summary on CORDIS.

The exposome concept promoting holistic characterization of the non-genetic factors that influence phenotype and health over the life course represents a transformative paradigm for health research as it goes beyond traditional risk assessment by incorporating multi-domain high-resolution longitudinal data, making the exposome concept particularly well-suited framework for precision public health and prevention strategies.

Since being introduced in 2005 by Christopher Wild, the exposome concept has catalysed significant scientific advances. Yet, the lack of a strategic framework for co-creation, harmonization, and documentation necessary to generate and disclose representative data has prevented the field from advancing at the pace of genomics, leaving major gaps in our understanding of the non-genetic contributions to chronic disease. EIRENE, the European InfrastRucturE for humaN Exposome, fills this gap and enables challenge-driven research advancing frontier knowledge and innovation in human exposome by providing open access to complementary high-end infrastructures, integrated services and harmonised data.

The EIRENE’s ambition to operationalize the exposome by advancing measurement and modelling technologies extends beyond Europe. The development of global infrastructural capacities supporting the integration of functional exposomics into biomedical and clinical research, innovation, and practice planned in the EIRENE Implementation Phase Project will transform the entire biomedical and public health enterprise, enable agnostic studies and the discovery of unforeseen links between environmental exposures and health outcomes.

New discoveries have the potential to both trigger biomedical innovation and European competitiveness in biotechnology and transform environmental policy through robust evidence of causal links.

Who is involved

OrganisationCityCountryRole
Masarykova univerzitaBrnoCzechiaCoordinator
Universitat WienWienAustriaParticipant
The University of QueenslandBrisbaneAustraliaParticipant
Vlaamse Instelling Voor Technologisch Onderzoek N.v.MolBelgiumParticipant
The Governors of the University of AlbertaEdmontonCanadaParticipant
Universite De GeneveGeneveSwitzerlandParticipant
Technologiko Panepistimio KyprouLemesosCyprusParticipant
Helmholtz Zentrum Muenchen Deutsches Forschungszentrum Fuer Gesundheit Und Umwelt GmbHNeuherbergGermanyParticipant
Aristotelio Panepistimio ThessalonikisThessalonikiGreeceParticipant
Ethniko Idryma ErevnonAthinaGreeceParticipant
Instituto De Salud Carlos IiiMadridSpainParticipant
Oulun YliopistoOuluFinlandParticipant
Institut National De La Sante Et De La Recherche MedicaleParisFranceParticipant
Haskoli IslandsReykjavikIcelandParticipant
Consiglio Nazionale Delle RicercheRomaItalyParticipant
Kokuritsu Daigaku Hojin Hokkaido DaigakuSapporoJapanParticipant
Laboratoire National De SanteDudelangeLuxembourgParticipant
Universiteit UtrechtUtrechtNetherlandsParticipant
FolkehelseinstituttetOsloNorwayParticipant
Orebro UniversityOrebroSwedenParticipant
X-officio Research ABLundSwedenParticipant
Institut Jozef StefanLjubljanaSloveniaParticipant
Slovenska Zdravotnicka Univerzita V BratislaveBratislavaSlovakiaParticipant
The University of BirminghamBirminghamUnited KingdomParticipant
Trustees of Columbia University in the City of New YorkNew YorkUnited StatesParticipant

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI